Giuseppe Giannini
Department of Experimental Medicine and Pathology
University La Sapienza
00161 Rome
Italy
Name/email consistency: high
- Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families. Giannini, G., Capalbo, C., Ristori, E., Ricevuto, E., Sidoni, T., Buffone, A., Cortesi, E., Marchetti, P., Scambia, G., Tomao, S., Rinaldi, C., Zani, M., Ferraro, S., Frati, L., Screpanti, I., Gulino, A. Breast Cancer Res. Treat. (2006)
- Molecular mechanism of HMGA1 deregulation in human neuroblastoma. Giannini, G., Cerignoli, F., Mellone, M., Massimi, I., Ambrosi, C., Rinaldi, C., Gulino, A. Cancer Lett. (2005)
- High mobility group A1 is a molecular target for MYCN in human neuroblastoma. Giannini, G., Cerignoli, F., Mellone, M., Massimi, I., Ambrosi, C., Rinaldi, C., Dominici, C., Frati, L., Screpanti, I., Gulino, A. Cancer Res. (2005)
- Human MRE11 is inactivated in mismatch repair-deficient cancers. Giannini, G., Ristori, E., Cerignoli, F., Rinaldi, C., Zani, M., Viel, A., Ottini, L., Crescenzi, M., Martinotti, S., Bignami, M., Frati, L., Screpanti, I., Gulino, A. EMBO Rep. (2002)